Healthcare Industry Insights: August 2019

Friday 30 August 2019

Healthcare Satellite Connectivity Market to Register 7.1% CAGR till 2025

U.S. healthcare satellite connectivity market, by component, 2014 - 2025 ($Billion)

The global Healthcare Satellite Connectivity Market is expected to reach USD 10.1 billion by 2025 according to a new report by Grand View Research, Inc. Globally, rising adoption of eHealth & other services and growing usage of technology platforms by hospitals & medical providers are crucial factors that boost the market growth.

Several governments are working toward providing improved basic medical facilities in rural areas with a key focus on improving connectivity infrastructure in healthcare and provision of enhanced care services. Some of the players in satellite connectivity are also undertaking projects in order to enhance healthcare provisions in underserved regions. For instance, Satellite Applications Catapult, a satellite technology company has collaborated with the Cayetano Heredia University in Northern Peru to improve medical services in the remote areas of Amazonia by providing enhanced connectivity solutions for mobile healthcare facilities along with the usage of eHealth and mHealth solutions.

Furthermore, the increasing pressure on medical facilities due to reduced budgets, ageing population, increasing number of patients with chronic conditions, shortage of adequately trained medical staff & doctors, lack of proper infrastructure in rural areas, and growing demand for real-time distance learning, telemedicine, and video services of higher quality are some of the other factors contributing to the growing adoption of satellite technology in healthcare. According to the Federal Communications Commission, rural areas are underserved by terrestrial broadband services as compared to urban areas. In 2016, 20 % did not have access to services at even 4 Mbps/1 Mbps and 31 % lacked access to 10 Mbps/1 Mbps broadband services. Provision of high-speed satellite technology would be a key solution to eliminate this geographic barrier and offer superior medical facilities.

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/healthcare-satellite-connectivity-market

Further key findings from the report suggest:

The system & software segment held majority of market share amongst the component segment in 2016 due to growing demand for data analytics in the healthcare sector
eHealth was the dominating application segment in 2016 due to growing government initiatives promoting integration of technology in healthcare
Hospitals & Clinics were the dominating end-use segment in 2016 with a share of 65.3% owing to the rising adoption of technology platforms for delivering medical care
Fixed mobile services held majority of the market share in 2016 in the connectivity segment with a share of 83%
The Asia Pacific market is expected to witness lucrative growth over the forecast period owing to the improving infrastructure and increasing patient pool

Key players include Inmarsat plc; Hughes Network Systems LLC, SES S.A., X2nSat, Expedition Communications, Globalstar, Eutelsat

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/

Hemodialysis and Peritoneal Dialysis Market: Current Scenarios and Growth Opportunities

U.S. hemodialysis and peritoneal dialysis market

The global Hemodialysis and Peritoneal Dialysis Market is expected to reach USD 108.5 billion by 2025, according to a new report by Grand View Research, Inc. Home-based dialysis treatment is anticipated to witness lucrative growth over the forecast period. Factors supporting this trend include; increasing development of small and automated products capable of providing treatment at home, rising number of individuals requiring daily procedures, growing number of individuals aptly trained to perform self-treatment, and initiatives by market participants toward raising education and training for home dialysis performance.

This industry is highly competitive with a few players holding relatively high proportion of the market share. However, the dominance of each player is in a separate region thereby limiting direct competition. For instance, Baxter generates higher revenue in Europe whereas Fresenius Medical Care AG & Co. KGaA gains higher revenue in the U.S. This scenario is anticipated to change over the forecast period owing to increasing globalization, and efforts by companies to expand their revenues and profits.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/hemodialysis-peritoneal-dialysis-market

Further key findings from the study suggest:

Hemodialysis dominates the industry with over 80.0% of the market share. These processes are performed in centers as well as in home settings primarily for adults. This enhanced applicability and benefits in comparison to peritoneal dialysis are expected to promote growth.
Presence of treatment centers and skilled personnel in abundance to carry out procedures is expected to drive the growth for these services. Factors responsible for higher market share of services may be classified into rising number of centers, development of training courses for home-based patients, and rising number of patients requiring dialysis treatment.
Home-based procedures are anticipated to witness the fastest growth over the forecast period. Development of small & portable systems along with with rising healthcare literacy amongst patients are vital impact rendering drivers.
Regionally, Asia Pacific is predicted to contribute higher revenue share over the forecast period. Improving healthcare infrastructure, rising disposable income, and growing incidence of conditions such as diabetes within the region are expected to support growth.
Players highlighted in the study include Fresenius Medical Care AG & Co. KGaA, NIPRO Medical Corporation, B. Braun Avitum AG, Baxter, and DaVita Inc. These companies are aggressively working toward purchasing dialysis centers or establishing new centers to cater to the rising demand.

Thursday 29 August 2019

Healthcare 3D Printing Market: Current Scenarios and Growth Opportunities

The global Healthcare 3D Printing Market is estimated to grow at a CAGR of 15.6% from 2014 to 2020 on account of growing need for manufacturing automated products. Rising geriatric population and increasing healthcare requirements across the globe have been majorly driving demand. Rise in number of orthopaedic and cardiovascular disorders occurring prominently among the aged population have resulted in an increased demand for these printing facilities.

Healthcare 3D printing market provides significant opportunities for manufacturing various medical equipment including dental implants, prosthetic limbs, hearing aids and orthotic footwear. Government initiatives to develop healthcare infrastructure and rising investments for R&D are some of the factors driving growth. The ability of the technology to reduce the risks involved with anaesthesia during prolonged surgeries has been another factor resulting in their increasing demand.The market is estimated to be worth USD 1.13 billion by 2020.

Polymers captured over 35% of the overall market share in 2013, dominating the raw material segment of the healthcare 3D printing industry. They are primarily used in bio-model printing.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/healthcare-3d-printing-market

Ceramics are commonly used for manufacturing tooth or mandible (jaw bone). Increasing occurrences of tooth problems including fractures and decays resulting in replacement of crowns or entire teeth is expected to propel demand for biocompatible materials including ceramics. The market is expected to grow at a CAGR of 15.6% over the forecast period.

Implants accounted for over 60.0% of the global market share in 2013. They are not only cost effective but also provide accuracy which is expected to fuel demand. Customized orthopaedic implants increase performance as they reduce time duration of surgeries. Also, it is convenient and less expensive to tailor 3D printed parts. Dental printers provide metal and wax prosthetics. Rising consumer awareness regarding maintaining oral health is expected to bolster growth over the projected period.

Photo-polymerization technology is extensively utilized by research organizations to produce accurate and efficient bio-models. It was valued over USD 140.0 million in 2013 dominating the global industry. However, laser beam melting is estimated to grow at a CAGR exceeding 16% from 2014 to 2020, thus, becoming the fastest growing technology. It is mostly used for producing orthopaedic implants.

North America accounted for over 35% of the global revenue dominating the regional industry in 2013. Rising awareness among patients, mounting investments for dedicated R&D facilities, advanced healthcare infrastructure coupled with development of 3D printing-based products are expected to drive demand in the region over the forecast period.

Rising demand for customized medical equipments and huge investments in R&D programs in Europe are expected to make it the fastest growing market in the next few years. Increasing healthcare investments and expenditures in emerging economies of Asia Pacific are expected to drive demand at a rapid pace over a period of six years.

Prominent players in the industryinclude Envision TEC, Materialise NV, Stratasys Inc., 3D Systems Software, Organovo, Bio-Rad Laboratories, SOLS, Metamason, Simbionix, RegenHU Ltd., Youbionic, 3D Matters Pte Ltd., 3D Systems Corporation (3DS), Roche Pharmaceuticals, Ekso Bionics, Renishaw plc., Delcam India, Robohand, Worrell, Archam, ALD Vacuum Technologies and Rainbow Biosciences.

Growth Factors of Atrial Fibrillation Market and In-Depth Analysis

The global Atrial Fibrillation Market is expected to reach USD 16.17 billion by 2020. Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population is expected to drive industry growth. Technological advancements in the field of microwave catheter ablation and radiofrequency along with rising occurrence of diseases caused by lifestyle habits such as drinking and smoking are further expected to fuel growth. Moreover, increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery are projected to bolster growth. Also, global aging population combined with the changes in lifestyle increasing the risks of obesity and high blood pressure is likely to drive demand.

Pharmacological products accounted for over 50% market share in 2013. Low prices of these products along with increasing use of anti-coagulants as an add-on therapy to non-pharmacological procedures are expected to drive demand.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/atrial-fibrillation-treatment-industry

North America accounted for over 40% of global revenue in 2013. High penetration of non-pharmacological procedure and sophisticated reimbursement frameworks has resulted in its substantial demand over the past few years. High patient awareness and healthcare expenditure levels also contributed significantly towards region growth.

Asia-Pacific is expected to witness substantial growth during the forecast period, growing at a CAGR of over 13% from 2015 to 2022. Rising demand for non-pharmacological treatments due to improvement in healthcare infrastructure, high disposable incomes, and growing patient awareness are a few factors accounting for its rapid growth.

Radiofrequency catheter ablation procedure segment is expected to be the fastest growing segment with a CAGR of over 12% over the forecast period. Technological advancements related to maneuverability which helps in making tight bends inside the heart, the optimal size of the lesion produced and lower time required to recover from of catheter ablation is expected to drive demand over the next seven years.

Maze surgery occupied the second largest share of non-pharmacological treatment market. It removes the need for life-long anti-coagulants based treatment while reducing the occurrence of strokes. Anti-coagulants held the dominant market share in pharmacological treatment market as it reduced the incidence of blood clots and strokes which in turn is likely to propel demand over the projected period.

Key industry players include Boston Scientific Corporation, St. Jude Medical Inc., Johnson & Johnson Ltd., Sanofi-Aventis, CardioFocus Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Corporation, Biosense Webster Inc., AtriCure Inc. and Endoscopic Technologies Inc. St. Jude Medical Inc. developed an Endosense’sTactiCath. The technology provides live feedback related to pressure applied during microwave catheter ablations and radiofrequency.

Influenza Diagnostics Market To Reach $3.3 Billion By 2024

The Influenza Diagnostics Market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season.

Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to the fact that it provides detailed analytical results, sharper turnaround times, and high throughput.

Hospitals held the highest market share in 2015, but Point-of-Care Testing (POCT) is anticipated to overtake and lead the market in the coming future, owing to the increasing usage of POCT because of its ease of use and short turnaround times.

North America dominates the market, due to a high focus of the government and healthcare bodies to control influenza.

Influenza Diagnostics Market – Enhanced Acceptance Of In Vitro Diagnostic Tests Will Drive Market Growth

Further Key Findings From the Study Suggest:

North America is anticipated to dominate the global influenza diagnostics market. The high adoption rates of in vitro diagnostics and presence of technologically advanced medical devices is expected to drive growth in the region.
The Asia Pacific region is anticipated to be the fastest growing region in the study period. This growth is attributed to factors such as increasing initiatives by the countries to counter the incidence of the disease. For instance, CDC reached a cooperative agreement with South-East Asian Region to fund non research-related bilateral influenza as a measure to respond to avian, seasonal, and pandemic influenza.
The RIDT segment is expected to grow at a significant rate compared to others and accounts for the largest share in 2015.
This market comprises several local as well as global players. Some of the major players of this vertical include Becton, Dickinson and Company, Roche Diagnostics, Alere, Quidel Corporation, and Thermo Fisher Scientific.

Neuroprosthetics Market Trends and Growth Opportunities

The global Neuroprosthetics Market is expected to reach USD 14.6 billion by 2024, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand for cost-effective and technologically advanced implants is expected to drive the demand for neuroprosthetics market in the coming years.

In addition, the associated high costs and side effects of conventional medications are responsible for the rising adoption rate of implants. For instance, the increasing adoption of Vagus Nerve Stimulation (VNS) therapy system over therapeutics such as antidepressants in the treatment of Alzheimer's disease, brain aneurysm, and strokes is propelling the overall market growth.

Moreover, the rising geriatric population prone to epilepsy opting for neural implantation over the conventional medication is exerting a positive effect on the overall industry growth.

North America Neuroprosthetics Market, By Type, 2014 - 2024 (USD Million)

Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/neuroprosthetics-market

Further key findings from the study suggest:

The motor prosthetic devices segment dominated in terms of revenue share and accounted for over 35.0% of the market in 2015, followed by visual cochlear implants. Whereas, retinal neuroprosthetics were identified as one of the fastest growing market segment owing to the rising penetration and the increasing R&D efforts pertaining to product innovation.

The Spinal Cord Stimulation (SCS) segment held the largest share at over 55.0% owing to the analgesic property of the SCS therapy used in the treatment of ischemic pain, failed back surgery syndrome, and complex refractory pain syndrome. Furthermore, it finds applications in intraspinal and epidural microstimulation for inducing leg movements. In addition, technological advancements in this segment is expected to further boost market growth in the near future. The sacral Nerve Stimulation (SNS) is expected to be the fastest growing segment over the forecast period due to its applications in chronic intractable pelvic ache and neurogenic bladder.

In the applications segment, motor neuron disorders held the largest segment due to the rising incidences of Parkinson’s disease and epilepsy. For instance, as per the report published by Parkinson’s disease Foundation in 2012, approximately 60,000 Americans were diagnosed with Parkinson’s disease each year and the number is expected to grow further over the forecast period thereby fueling this segment’s growth.

In 2015, North America dominated the overall neuroprosthetics market at over 43.0% owing to the large presence of neural implants manufacturers, higher R&D investments, and the availability of funds from both government and private institutes. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH)in collaboration with the federal agencies are instrumental in providing funds to support R&D initiatives for the further development of neural implants.

Asia Pacific is anticipated to be the fastest growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures along with the rising awareness levels amongst consumers

Strategic collaborations and mergers & acquisitions are expected to keep the industry rivalry level high over the forecast period

Healthcare Payer BPO Market Trends, Manufacturer, Scope, Overview and Outlook

Global Healthcare Payer BPO Market is expected to reach over USD 34.2 billion by 2022 according to a new report by Grand View Research Inc. Key drivers attributing to the growth are ObamaCare, shift to ICD-10 coding system, growing geriatric population, increasing disease burden and penetration of insurance coverage in emerging economies.

In 2013, as per estimates published by the America’s Health Insurance Plans (AHIP), which is the national trade association representing the health insurance industry, one-sixth of the U.S. economy or nearly USD 2.7 trillion is dedicated to healthcare spending and the number is expected to increase year on year. However, the healthcare system is not able to reap the benefits of such expenditure due to process inefficiencies and use of redundant systems. The estimated loss due to such inefficiencies is nearly 800 billion or approximately 20 to 30 percent of the overall expenditure.

Increasing healthcare expenditure is a major concern for the U.S. and all the other major economies. In order to reduce the economic burden and provide universal access to healthcare, governments are encouraging outsourcing of payer services to onshore or offshore locations.

North America payer BPO market by type of service, 2012 - 2022 (USD Billion)

The shift from ICD-9 coding system to ICD-10 coding has created huge work load for the payers to upgrade their systems, train their staff and has significantly increased the financial burden. The ICD-9 code system had 13,000 codes, where as the ICD-10 code system has nearly 68,000 codes. This shift from the legacy system to the latest system has significantly increased the need for medical coding, accounting, HR, and other technical professionals, thereby is expected to positively reinforce the healthcare payer BPO outsourcing market growth in the next seven years.

Browse Details of Reports @
http://www.grandviewresearch.com/industry-analysis/healthcare-payer-bpo-market

Further key findings from the study suggest:

In 2014, claims processing services accounted for the maximum share of approximately 55%. Key reasons attributed are growth in new member enrolments due to ObamaCare, increase in disease burden. For instance, as per data published by ObamaCare and CMS, in 2013 nearly 8 million people enrolled through the marketplace and nearly 11.7 million people were enrolled in 2015.
However, Asia Pacific is expected to be the fastest growing market over the forecast period owing to high economic development in the region, favorable government initiatives and growth in insurance penetration across urban and rural centers. For instance, the Indian government’s initiatives such as Pradhan Mantri Suraksha Bima Yojana and Pradhan Mantri Jeevan Jyoti Bima Yojana, are expected to benefit millions of people seeking life insurance and personal accident coverage and as consequence is expected to contribute to the healthcare payer BPO market expansion over the forecast period.
Some key players operating in the market include, Xerox Corporation, Genpact Limited, Wipro Limited, Capgemini, Hinduja Global Solutions, HCL Technologies Ltd, Cognizant Technology Solutions, EXLService Holdings Inc., and Accenture. These players dominate the market owing to their strong product and service delivery portfolio, and presence of large customer base in the U.S and European markets.

Wednesday 28 August 2019

Microbiology & Bacterial Culture for Industrial Testing Market Worth $8.0 Billion By 2025

The global Microbiology & Bacterial Culture For Industrial (Food, Water, Bioenergy) Testing Market size is expected to reach USD 8.0 billion by 2025, according to a new report by Grand View Research, Inc. Growing concern pertaining to safety of feed supply provided to livestock is recognized as a high impact rendering factor for growth. Use of microorganisms for enhancing bioenergy reproducibility is expected to gain ground in the future microbiology & bacterial culture media & reagent market. This anticipated growth is attributed to the ongoing research and studies to enhance the application of microbial cell culture in biofuel production.

In addition, growing knowledge pertaining to the significance of bacteria in agriculture and industrial applications is expected to positively influence the progress of microbial cell culture market for agricultural research. Microbial testing to verify cleanliness or infestation of any pathogen in swab samples from a factory helps maintain factory environment. Microbial tests, as a verification of finished products, are required for product authorization. Microbiology food testing at various stages of development is found to serve as high impact rendering driver.

U.S. microbiology & bacterial culture for industrial testing market, by application, 2014 - 2025 (USD Million)

In addition, various countries are establishing risk management strategies that include new quality control criteria as a preventive measure to curb outbreak of microbial infection. These criteria incorporate sample checking in context to microbial parameters at various stages of production to maintain quality and safety. This is anticipated to directly translate into the growth in revenue for this market at a larger level.

Browse Details of Report @

http://www.grandviewresearch.com/industry-analysis/microbiology-culture-market

Further key findings from the report suggest:

Media is estimated to account for the largest revenue share due to the availability of ready-to-use and dehydrated media in customized forms
Higher adoption of bacteria in industrial production is attributed to larger share of bacterial media
Bacterial media is anticipated to maintain its dominance over the forecast period as a consequence of higher usage in the industrial bio production
In 2016, food testing was the largest revenue grossing segment of the applications of microbiology culture media and reagents
Large application of these products for food and animal feed testing in order to ensure quality of end product
Animal feed testing is anticipated to showcase lucrative growth over the study period due to escalation in the outbreak of animal diseases caused due to the consumption of contaminated feed
North American region holds a larger share in terms of revenue. A fair share can be credited to the innovative technology available for processing media and organisms required for bio-production
The industry in Asia Pacific is projected to exhibit potential progress in the coming years as a consequence of various developments across major economies, especially in the processed food industry
Lately, many multinational companies have shown huge interest in this region by investing heavily in setting up new facilities and promoting distributor networks to meet demand
Key players operating include Bio-Rad Laboratories, Inc., bioMérieux SA, Thermo Fisher Scientific, Inc., Merck KGaA, Neogen Corporation, HiMedia Laboratories, Eiken Chemical Co., Ltd.

About Us:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/